Evidence map›Paper›PMID 24019894›Full record

ArticlePloS one2013

p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophils.

Asako Itakura, Joseph E Aslan, Branden T Kusanto, Kevin G Phillips, Juliana E Porter, Paul K Newton, Xiaolin Nan, Robert H Insall, Jonathan Chernoff, Owen J T McCarty

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. KRIT1 in vascular biology and beyond.Bioscience reports · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Random walk and cell morphology dynamics inFrontiers in cell and developmental biology · 2023
    Article
  13. Sex-Based Differences in Human Neutrophil Chemorepulsion.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  14. Article
  15. Frontiers in immunology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Asako ItakuraDepartment of Cell and Developmental Biology, Oregon Health and Science University, Portland, Oregon, United States of America.
Joseph E Aslan
Branden T Kusanto
Kevin G Phillips
Juliana E Porter
Paul K Newton
Xiaolin Nan
Robert H Insall
Jonathan Chernoff
Owen J T McCarty
Oregon Health & Science University · USUniversity of Southern California · USCancer Research UK Scotland Institute · GBFox Chase Cancer Center · US

Funding

TopologyU54CA143906 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KUHN, PETER · 2009 to 2014
$10.2M
Characterization of Coagulation Factor-platelet Interactions: Role of FXIR01HL101972 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Owen J McCarty · 2010 to 2026
$8.5M
Targeting the Kinome in Neurofibromatosis type 1R01CA142928 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 2010 to 2019
$3.9M
Cancer Research UK 15672NCI NIH HHS R01 CA142928NCI NIH HHS R01CA142928NCI NIH HHS U54 CA143906NCI NIH HHS U54CA143906NHLBI NIH HHS R01 HL101972NHLBI NIH HHS R01HL101972
6 · The paper itself

Abstract

Neutrophils serve as a first line of defense in innate immunity owing in part to their ability to rapidly migrate towards chemotactic factors derived from invading pathogens. As a migratory function, neutrophil chemotaxis is regulated by the Rho family of small GTPases. However, the mechanisms by which Rho GTPases orchestrate cytoskeletal dynamics in migrating neutrophils remain ill-defined. In this study, we characterized the role of p21-activated kinase (PAK) downstream of Rho GTPases in cytoskeletal remodeling and chemotactic processes of human neutrophils. We found that PAK activation occurred upon stimulation of neutrophils with f-Met-Leu-Phe (fMLP), and PAK accumulated at the actin-rich leading edge of stimulated neutrophils, suggesting a role for PAK in Rac-dependent actin remodeling. Treatment with the pharmacological PAK inhibitor, PF3758309, abrogated the integrity of RhoA-mediated actomyosin contractility and surface adhesion. Moreover, inhibition of PAK activity impaired neutrophil morphological polarization and directional migration under a gradient of fMLP, and was associated with dysregulated Ca(2+) signaling. These results suggest that PAK serves as an important effector of Rho-family GTPases in neutrophil cytoskeletal reorganization, and plays a key role in driving efficient directional migration of human neutrophils.

Indexed as

Chemotaxis, LeukocyteBlotting, WesternCytoskeletonEnzyme ActivationFluorescent Antibody TechniqueHumansMicroscopy, FluorescenceNeutrophilsN-Formylmethionine Leucyl-Phenylalaninep21-Activated KinasesProtein TransportN-Formylmethionine Leucyl-Phenylalaninep21-Activated Kinases

Identifiers

PMID24019894
PMCPMC3760889
OpenAlexW2057320974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.